Orthofix International | OFIX - Cash And Equivalent


Orthofix International reported $120.28M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Accuray USD 41.29M 22.05M Dec/2025
AngioDynamics USD 41.64M 14.26M Sep/2025
Artivion USD 55.76M 9.14M Mar/2026
AtriCure USD 146.16M 21.26M Mar/2026
Dexcom USD 1.12B 200.5M Mar/2026
EDAP TMS EUR 29.84M 4.35M Dec/2024
Globus Medical USD 560.95M 34.79M Mar/2026
Inogen USD 106.48M 2.79M Sep/2025
Insulet USD 480.4M 235.7M Mar/2026
Integra LifeSciences USD 236.81M 1.76M Mar/2026
J&J USD 21.69B 1.98B Mar/2026
Medtronic USD 1.15B 135M Dec/2025
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Orthofix International USD 120.28M 38.25M Mar/2026
Plus Therapeutics USD 3.02M 1.23M Mar/2026
STAAR Surgical USD 153.15M 23M Dec/2025
Stryker USD 2.88B 1.13B Mar/2026
Surmodics USD 36.11M 11.81M Sep/2024
Tandem Diabetes Care USD 179.32M 88.69M Mar/2026
Teleflex USD 309.41M 69.15M Mar/2026
Veracyte USD 263.14M 99.44M Mar/2026
Zimmer Biomet Holdings USD 424.2M 167.7M Mar/2026